# OnCo record nct05794906 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05794906/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05794906", "NCT05794906" ;
  schema:name "A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer"@en ;
  schema:alternateName "ARASTEP"@en ;
  schema:description "A phase 3 trial of Darolutamide in prostate cancer, run by Bayer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05794906/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05794906> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2023-04-03" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-bcr/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:drugs <https://onco.cc/drugs/darolutamide/> ;
  onco:companies <https://onco.cc/companies/bayer/> .